Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Carfilzomib | hsa00220 | Arginine biosynthesis | 1.54E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Carfilzomib | hsa00240 | Pyrimidine metabolism | 6.59E-03 | 4 | P21589, P32320, P27707, P04183 | NT5E, CDA, DCK, TK1 | More | | Carfilzomib | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.48E-02 | 2 | P40926, P15104 | MDH2, GLUL | More | | Carfilzomib | hsa00910 | Nitrogen metabolism | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Carfilzomib | hsa00920 | Sulfur metabolism | 1.78E-02 | 1 | Q16762 | TST | More | | Carfilzomib | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 3.10E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Carfilzomib | hsa00982 | Drug metabolism - cytochrome P450 | 3.10E-02 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Carfilzomib | hsa00983 | Drug metabolism - other enzymes | 2.27E-03 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Carfilzomib | hsa01100 | Metabolic pathways | 2.44E-02 | 25 | Q9Y234, O00764, Q99707, O14732, P27707, P21589, P04183, P32320, P36959, P22748, P06280, P33260, Q02252, O14772, Q9HCC0, P33121, P42330, Q13093, Q9NY28, Q9BX95, Q9P2R7, Q9UHY7, P06737, Q16718, Q02809 | LIPT1, PDXK, MTR, IMPA2, DCK, NT5E, TK1, CDA, GMPR, CA4, GLA, CYP2C18, ALDH6A1, FPGT, MCCC2, ACSL1, AKR1C3, PLA2G7, GALNT8, SGPP1, SUCLA2, ENOPH1, PYGL, NDUFA5, PLOD1 | More | | Carfilzomib | hsa03013 | RNA transport | 2.37E-02 | 8 | P52298, O14893, P61326, Q7Z3B4, P35658, O75822, P78345, Q9Y6A5 | NCBP2, GEMIN2, MAGOH, NUP54, NUP214, EIF3J, RPP38, TACC3 | More | | Carfilzomib | hsa03040 | Spliceosome | 5.25E-04 | 9 | O43143, P17844, P08579, P51991, P61978, Q13595, Q07955, P84103, P11142 | DHX15, DDX5, SNRPB2, HNRPA3, HNRPK, TRA2A, SFRS1, SFRS3, HSPA8 | More | | Carfilzomib | hsa03050 | Proteasome | 1.35E-03 | 2 | P28074, P40306 | PSMB5, PSMB10 | More | | Carfilzomib | hsa04014 | Ras signaling pathway | 4.12E-02 | 5 | P20827, P49767, Q14644, P0DP23, P63218 | EFNA1, VEGFC, RASA3, CALM1, GNG5 | More | | Carfilzomib | hsa04020 | Calcium signaling pathway | 3.36E-03 | 6 | Q16566, P30679, O15399, P0DP23, P23634, P49767 | CAMK4, GNA15, GRIN2D, CALM1, ATP2B4, VEGFC | More | | Carfilzomib | hsa04060 | Cytokine-cytokine receptor interaction | 5.39E-03 | 10 | P27930, P08476, Q13651, Q9HBE5, Q9UBD3, P47992, P01375, P09341, P18510, Q93038 | IL1R2, INHBA, IL10RA, IL21R, XCL2, XCL1, TNF, CXCL1, IL1RN, TNFRSF25 | More | | Carfilzomib | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.34E-02 | 5 | P09341, P47992, Q9UBD3, Q13651, P01375 | CXCL1, XCL1, XCL2, IL10RA, TNF | More | | Carfilzomib | hsa04064 | NF-kappa B signaling pathway | 6.00E-03 | 8 | O00463, P01375, Q04759, Q16548, P06239, Q13315, P24522, P09341 | TRAF5, TNF, PRKCQ, BCL2A1, LCK, ATM, GADD45A, CXCL1 | More | | Carfilzomib | hsa04122 | Sulfur relay system | 1.78E-02 | 1 | Q16762 | TST | More | | Carfilzomib | hsa04136 | Autophagy - other | 3.53E-02 | 1 | O94817 | ATG12 | More | | Carfilzomib | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | | Carfilzomib | hsa04145 | Phagosome | 6.34E-03 | 7 | Q15080, P14598, Q13509, P68371, P05164, O60603, P35443 | NCF4, NCF1, TUBB3, TUBB2C, MPO, TLR2, THBS4 | More | | Carfilzomib | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | | Carfilzomib | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Carfilzomib | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.46E-02 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Carfilzomib | hsa04371 | Apelin signaling pathway | 4.16E-02 | 4 | P63218, Q13485, Q16566, P0DP23 | GNG5, SMAD4, CAMK4, CALM1 | More | | Carfilzomib | hsa04512 | ECM-receptor interaction | 4.78E-02 | 1 | Q16787 | LAMA3 | More | | Carfilzomib | hsa04514 | Cell adhesion molecules | 2.37E-02 | 2 | P16109, O00501 | SELP, CLDN5 | More | | Carfilzomib | hsa04530 | Tight junction | 3.82E-02 | 2 | O00501, P24844 | CLDN5, MYL9 | More | | Carfilzomib | hsa04610 | Complement and coagulation cascades | 4.48E-02 | 3 | P01042, P09871, P11215 | KNG1, C1S, ITGAM | More | | Carfilzomib | hsa04612 | Antigen processing and presentation | 9.89E-03 | 7 | P13765, P48382, P26715, P26717, Q13241, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, CD8A, TNF | More | | Carfilzomib | hsa04640 | Hematopoietic cell lineage | 4.96E-02 | 6 | P27930, P25063, P09693, P01732, P13765, P01375 | IL1R2, CD24, CD3G, CD8A, HLA-DOB, TNF | More | | Carfilzomib | hsa04650 | Natural killer cell mediated cytotoxicity | 2.94E-03 | 8 | P01375, P06239, O60880, P20963, Q13241, P26718, P26717, P26715 | TNF, LCK, SH2D1A, CD247, KLRD1, KLRK1, KLRC2, KLRC1 | More | | Carfilzomib | hsa04657 | IL-17 signaling pathway | 2.29E-02 | 5 | O00463, P09341, P14780, P80188, P01375 | TRAF5, CXCL1, MMP9, LCN2, TNF | More | | Carfilzomib | hsa04658 | Th1 and Th2 cell differentiation | 1.26E-03 | 8 | Q04759, P20963, P09693, P06239, Q14765, P23771, Q9UL17, P13765 | PRKCQ, CD247, CD3G, LCK, STAT4, GATA3, TBX21, HLA-DOB | More | | Carfilzomib | hsa04659 | Th17 cell differentiation | 3.55E-03 | 8 | Q04759, P06239, P13765, Q9HBE5, Q9UL17, P23771, P09693, P20963 | PRKCQ, LCK, HLA-DOB, IL21R, TBX21, GATA3, CD3G, CD247 | More | | Carfilzomib | hsa04660 | T cell receptor signaling pathway | 2.94E-03 | 8 | P01375, Q04759, O95267, Q08881, P20963, P09693, P01732, P06239 | TNF, PRKCQ, RASGRP1, ITK, CD247, CD3G, CD8A, LCK | More | | Carfilzomib | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Carfilzomib | hsa04720 | Long-term potentiation | 1.79E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | | Carfilzomib | hsa04724 | Glutamatergic synapse | 4.48E-02 | 3 | O15399, P63218, Q9NSB8 | GRIN2D, GNG5, HOMER2 | More | | Carfilzomib | hsa04725 | Cholinergic synapse | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Carfilzomib | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | | Carfilzomib | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | | Carfilzomib | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | | Carfilzomib | hsa04915 | Estrogen signaling pathway | 2.75E-03 | 5 | Q99941, P18848, P51828, P07900, P11142 | CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8 | More | | Carfilzomib | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Carfilzomib | hsa04925 | Aldosterone synthesis and secretion | 2.31E-04 | 7 | Q99941, P18848, P51828, P0DP23, Q16566, Q13557, P23634 | CREBL1, ATF4, ADCY7, CALM1, CAMK4, CAMK2D, ATP2B4 | More | | Carfilzomib | hsa04926 | Relaxin signaling pathway | 3.34E-02 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Carfilzomib | hsa04927 | Cortisol synthesis and secretion | 4.16E-03 | 3 | Q99941, P18848, P51828 | CREBL1, ATF4, ADCY7 | More | | Carfilzomib | hsa04928 | Parathyroid hormone synthesis, secretion and action | 2.17E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Carfilzomib | hsa04934 | Cushing syndrome | 1.12E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | | Carfilzomib | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Carfilzomib | hsa04964 | Proximal tubule bicarbonate reclamation | 2.93E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Carfilzomib | hsa04973 | Carbohydrate digestion and absorption | 2.41E-02 | 1 | P13866 | SLC5A1 | More | | Carfilzomib | hsa04976 | Bile secretion | 4.19E-02 | 1 | P13866 | SLC5A1 | More | | Carfilzomib | hsa05017 | Spinocerebellar ataxia | 2.43E-02 | 1 | P28074 | PSMB5 | More | | Carfilzomib | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | | Carfilzomib | hsa05031 | Amphetamine addiction | 6.41E-03 | 3 | Q13557, Q99941, P18848 | CAMK2D, CREBL1, ATF4 | More | | Carfilzomib | hsa05034 | Alcoholism | 1.05E-02 | 6 | O15399, Q16566, P0DP23, P63218, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNG5, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Carfilzomib | hsa05132 | Salmonella infection | 1.46E-02 | 9 | Q13489, P10415, O75369, Q96A32, O60603, Q9BQS8, Q13561, Q13509, P68371 | BIRC3, BCL2, FLNB, MYLPF, TLR2, FYCO1, DCTN2, TUBB3, TUBB2C | More | | Carfilzomib | hsa05133 | Pertussis | 1.70E-03 | 4 | P11215, P0DP23, P23528, P09871 | ITGAM, CALM1, CFL1, C1S | More | | Carfilzomib | hsa05146 | Amoebiasis | 7.00E-03 | 7 | P09341, P27930, P01375, P05089, P22694, P12814, P08311 | CXCL1, IL1R2, TNF, ARG1, PRKACB, ACTN1, CTSG | More | | Carfilzomib | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Carfilzomib | hsa05202 | Transcriptional misregulation in cancer | 5.05E-04 | 16 | Q15532, Q13315, P41732, P14780, P27930, P14923, Q15744, Q16548, Q13489, O15550, P35226, P05164, P12838, P08246, Q9C0K0, P24522 | SS18, ATM, TSPAN7, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, UTX, BMI1, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | | Carfilzomib | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | | Carfilzomib | hsa05204 | Chemical carcinogenesis | 4.92E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Carfilzomib | hsa05222 | Small cell lung cancer | 4.78E-02 | 1 | Q16787 | LAMA3 | More | | Carfilzomib | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 4.34E-02 | 5 | O95267, P20963, P09693, P06239, Q04759 | RASGRP1, CD247, CD3G, LCK, PRKCQ | More | | Carfilzomib | hsa05310 | Asthma | 3.20E-02 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Carfilzomib | hsa05321 | Inflammatory bowel disease | 1.25E-03 | 6 | P01375, P13765, Q14765, Q9UL17, P23771, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, GATA3, IL21R | More | | Carfilzomib | hsa05322 | Systemic lupus erythematosus | 3.90E-02 | 6 | P08246, P08311, P01375, P13765, Q16778, P12814 | ELA2, CTSG, TNF, HLA-DOB, HIST2H2BE, ACTN1 | More | | Carfilzomib | hsa05332 | Graft-versus-host disease | 2.55E-02 | 4 | P13765, P01375, P26715, Q13241 | HLA-DOB, TNF, KLRC1, KLRD1 | More | | |